Lin Wei insider trades
Open-market stock purchases and sales by Lin Wei, Chief Medical Officer at Revolution Medicines, Inc, from SEC Form 4 filings since Feb 1, 2022.
Open-market stock purchases and sales by Lin Wei, Chief Medical Officer at Revolution Medicines, Inc, from SEC Form 4 filings since Feb 1, 2022.